Day One Biopharmaceuticals, Inc. (DAWN) Ownership

$7.92

$0.42 (-5.04%)
Last update: 04:00 PM EST
Day's range
$7.91
Day's range
$8.49

Day One Biopharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 10.10 M $71.19 M   -10.98% 9.80%
BLACKROCK, INC. 11/12/2025 9.00 M $63.46 M   -8.43% 8.73%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 11/13/2025 6.43 M $45.33 M   0.00% 6.24%
VANGUARD GROUP INC 11/07/2025 6.18 M $43.58 M   0.08% 6.00%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2025 4.71 M $33.17 M   26.38% 4.57%
FRANKLIN RESOURCES INC 11/13/2025 3.48 M $24.51 M   -15.15% 3.37%
RUBRIC CAPITAL MANAGEMENT LP 11/14/2025 3.38 M $23.81 M   100.00% 3.28%
STATE STREET CORP 11/14/2025 3.24 M $22.85 M   20.48% 3.14%
VESTAL POINT CAPITAL, LP 11/14/2025 2.68 M $18.86 M   -10.83% 2.60%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 2.37 M $16.73 M   -36.25% 2.30%
ALYESKA INVESTMENT GROUP, L.P. 11/17/2025 2.21 M $15.60 M   -26.56% 2.15%
BRAIDWELL LP 11/14/2025 2.18 M $15.38 M   0.00% 2.12%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.76 M $12.42 M   2.85% 1.71%
AIGH CAPITAL MANAGEMENT LLC 10/31/2025 1.52 M $10.72 M   100.00% 1.48%
MAK CAPITAL ONE LLC 11/14/2025 1.45 M $10.21 M   100.00% 1.41%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 1.38 M $9.76 M   100.00% 1.34%
GOLDMAN SACHS GROUP INC 11/14/2025 1.37 M $9.67 M   -18.91% 1.33%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2025 1.32 M $9.31 M   1.80% 1.28%
ALGERT GLOBAL LLC 11/14/2025 1.32 M $9.29 M   45.36% 1.28%
MORGAN STANLEY 11/14/2025 1.30 M $9.19 M   -3.63% 1.27%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 1.22 M $8.62 M   -13.64% 1.19%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.19 M $8.40 M   23.45% 1.16%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 1.17 M $8.23 M   23.67% 1.13%
DAFNA CAPITAL MANAGEMENT LLC 11/14/2025 999.16 K $7.04 M   13.65% 0.97%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 905.48 K $6.38 M   -9.50% 0.88%
MILLENNIUM MANAGEMENT LLC 11/14/2025 693.32 K $4.89 M   -42.60% 0.67%
CITADEL ADVISORS LLC 11/14/2025 663.21 K $4.68 M   -5.75% 0.64%
STONEPINE CAPITAL MANAGEMENT, LLC 11/13/2025 647.38 K $4.56 M   43.86% 0.63%
NORTHERN TRUST CORP 11/14/2025 629.59 K $4.44 M   3.02% 0.61%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 610.06 K $4.30 M   5.41% 0.59%
J. GOLDMAN & CO LP 11/14/2025 569.62 K $4.02 M   2.18% 0.55%
KENNEDY CAPITAL MANAGEMENT LLC 11/13/2025 540.38 K $3.81 M   19.15% 0.52%
BARCLAYS PLC 11/12/2025 347.19 K $2.45 M   -0.27% 0.34%
HRT FINANCIAL LP 11/14/2025 321.38 K $2.27 M   100.00% 0.31%
BANK OF NEW YORK MELLON CORP 11/03/2025 306.18 K $2.16 M   -0.54% 0.30%
PALE FIRE CAPITAL SE 11/13/2025 302.47 K $2.13 M   768.09% 0.29%
PARKMAN HEALTHCARE PARTNERS LLC 11/14/2025 301.75 K $2.13 M   -39.65% 0.29%
JANE STREET GROUP, LLC 11/14/2025 279.34 K $1.97 M   100.00% 0.27%
PARKWOOD LLC 11/14/2025 275.00 K $1.94 M   0.00% 0.27%
JUMP FINANCIAL, LLC 11/13/2025 272.55 K $1.92 M   100.00% 0.26%
SCHRODER INVESTMENT MANAGEMENT GROUP 11/13/2025 270.22 K $1.89 M   50.01% 0.26%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 268.29 K $1.89 M   113.84% 0.26%
TREXQUANT INVESTMENT LP 11/14/2025 266.58 K $1.88 M   130.95% 0.26%
FISHER ASSET MANAGEMENT, LLC 11/12/2025 220.16 K $1.55 M   -0.82% 0.21%
UBS GROUP AG 11/13/2025 209.72 K $1.48 M   134.39% 0.20%
QUEST PARTNERS LLC 11/03/2025 185.01 K $1.30 M   1,065.61% 0.18%
SPHERA FUNDS MANAGEMENT LTD. 11/14/2025 175.37 K $1.24 M   0.00% 0.17%
NUVEEN, LLC 11/12/2025 150.37 K $1.06 M   0.00% 0.15%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 150.35 K $1.06 M   4.81% 0.15%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 11/14/2025 138.42 K $975.86 K   -47.43% 0.13%

Day One Biopharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 222 institutional investors and hedge funds held shares of Day One Biopharmaceuticals, Inc.. The most heavily invested institutionals were:

FMR LLC: 10.1 M

BlackRock, Inc.: 9 M

Atlas Venture Life Science Advisors, LLC: 6.43 M

VANGUARD GROUP INC: 6.18 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 4.71 M

FRANKLIN RESOURCES INC: 3.48 M

82.98% of Day One Biopharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 91.98 M shares in the last 24 months. This purchase volume represents approximately $728.49 M in transactions.